West China Hospital
Chengdu, Sichuan, 610041, China
NCT Number: NCT02942797
This is a prospective study of patients diagnosed with chronic obstructive pulmonary disease (COPD) with respiratory failure and admitted in West China Hospital during April 2017 to March 2019. The following variables will be prospectively studied: age, sex, height, weight, respiratory function indicators, arterial blood gas analysis results, biochemical data, nutritional risk screening 2002 (NRS 2002) score, short-term and long-term prognostic outcomes. The purpose of this study is to assess whether NRS 2002 is a useful prognosis predictor in COPD patients with respiratory failure.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Chengdu, Sichuan, 610041, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 2 years
Time frame: up to 2 years
Time frame: up to 2 years
Time frame: up to 2 years
Time frame: up to 2 years
West China Hospital
Other
Nutritional Risk Screening 2002 Should be Used to Predict Prognostic Outcomes in Chronic Obstructive Pulmonary Disease With Respiratory Failure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03383601
Chronic Disease, Disease Attributes
Almaty, Kazakhstan
View Trial DetailsNCT02668250
Alcohol-Related Disorders, Alcoholism
Amiens, France
View Trial DetailsNCT04630743
Breathlessness, Cardiovascular Diseases
Cologne, North Rhine-Westphalia, Germany
View Trial DetailsNCT02942784
Chronic Disease, Disease Attributes
Chengdu, Sichuan, China
View Trial Details